These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34808406)

  • 1. Peptidomimetic analogues of an Arg-Trp-x-x-Trp motif responsible for interaction of translocase MraY with bacteriophage ϕX174 lysis protein E.
    Kerr RV; Fairbairn JA; Merritt AT; Bugg TDH
    Bioorg Med Chem; 2021 Dec; 52():116502. PubMed ID: 34808406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel inhibition site in translocase MraY based upon the site of interaction with lysis protein E from bacteriophage ϕX174.
    Rodolis MT; Mihalyi A; O'Reilly A; Slikas J; Roper DI; Hancock RE; Bugg TD
    Chembiochem; 2014 Jun; 15(9):1300-8. PubMed ID: 24895118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage ϕX174 lysis protein E, and cationic antibacterial peptides.
    Bugg TD; Rodolis MT; Mihalyi A; Jamshidi S
    Bioorg Med Chem; 2016 Dec; 24(24):6340-6347. PubMed ID: 27021004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of the uridyl peptide antibiotics: an unexpected link to a protein-protein interaction site in translocase MraY.
    Rodolis MT; Mihalyi A; Ducho C; Eitel K; Gust B; Goss RJ; Bugg TD
    Chem Commun (Camb); 2014 Nov; 50(86):13023-5. PubMed ID: 25222373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.
    Mihalyi A; Jamshidi S; Slikas J; Bugg TD
    Bioorg Med Chem; 2014 Sep; 22(17):4566-71. PubMed ID: 25127465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the transmembrane domain of lysis protein E from bacteriophage phiX174 with bacterial translocase MraY and peptidyl-prolyl isomerase SlyD.
    Mendel S; Holbourn JM; Schouten JA; Bugg TDH
    Microbiology (Reading); 2006 Oct; 152(Pt 10):2959-2967. PubMed ID: 17005977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of cell selective α/β-diastereomeric peptidomimetic with potent in vivo antibacterial activity against methicillin resistant S. Aureus.
    Dewangan RP; Bisht GS; Singh VP; Yar MS; Pasha S
    Bioorg Chem; 2018 Feb; 76():538-547. PubMed ID: 29310083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of natural antimicrobial peptides versus peptidomimetic analogues: a systematic review.
    Hellewell L; Gilani NM; Stanton CJ; Pelligand L; Franzyk H; Guardabassi L; Good L
    Future Med Chem; 2022 Dec; 14(24):1899-1921. PubMed ID: 36421051
    [No Abstract]   [Full Text] [Related]  

  • 9. Minimal requirements for inhibition of MraY by lysis protein E from bacteriophage ΦX174.
    Tanaka S; Clemons WM
    Mol Microbiol; 2012 Sep; 85(5):975-85. PubMed ID: 22742425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptive evolution of Escherichia coli to an α-peptide/β-peptoid peptidomimetic induces stable resistance.
    Hein-Kristensen L; Franzyk H; Holch A; Gram L
    PLoS One; 2013; 8(9):e73620. PubMed ID: 24040003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: synthesis, antibacterial evaluation and preliminary mechanism of action studies.
    Tague AJ; Putsathit P; Hammer KA; Wales SM; Knight DR; Riley TV; Keller PA; Pyne SG
    Eur J Med Chem; 2019 Apr; 168():386-404. PubMed ID: 30831407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospho-MurNAc-pentapeptide translocase (MraY) as a target for antibacterial agents and antibacterial proteins.
    Bugg TD; Lloyd AJ; Roper DI
    Infect Disord Drug Targets; 2006 Jun; 6(2):85-106. PubMed ID: 16789873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antimicrobial activity against Pseudomonas aeruginosa of macrocyclic β-hairpin peptidomimetic antibiotics containing N-methylated amino acids.
    Vetterli SU; Moehle K; Robinson JA
    Bioorg Med Chem; 2016 Dec; 24(24):6332-6339. PubMed ID: 27240465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
    Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
    Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide/β-Peptoid Hybrids with Ultrashort PEG-Like Moieties: Effects on Hydrophobicity, Antibacterial Activity and Hemolytic Properties.
    Frederiksen N; Louka S; Mudaliar C; Domraceva I; Kreicberga A; Pugovics O; Żabicka D; Tomczak M; Wygoda W; Björkling F; Franzyk H
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design.
    Mashalidis EH; Lee SY
    J Mol Biol; 2020 Aug; 432(18):4946-4963. PubMed ID: 32199982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and molecular modeling of urea-containing MraY inhibitors.
    Oliver M; Le Corre L; Poinsot M; Corio A; Madegard L; Bosco M; Amoroso A; Joris B; Auger R; Touzé T; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    Org Biomol Chem; 2021 Jul; 19(26):5844-5866. PubMed ID: 34115086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norbornane-based cationic antimicrobial peptidomimetics targeting the bacterial membrane.
    Hickey SM; Ashton TD; Boer G; Bader CA; Thomas M; Elliott AG; Schmuck C; Yu HY; Li J; Nation RL; Cooper MA; Plush SE; Brooks DA; Pfeffer FM
    Eur J Med Chem; 2018 Dec; 160():9-22. PubMed ID: 30316060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Target Interaction of Naturally Occurring Muraymycin Nucleoside Antibiotics.
    Koppermann S; Cui Z; Fischer PD; Wang X; Ludwig J; Thorson JS; Van Lanen SG; Ducho C
    ChemMedChem; 2018 Apr; 13(8):779-784. PubMed ID: 29438582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.
    Kwak SH; Lim WY; Hao A; Mashalidis EH; Kwon DY; Jeong P; Kim MJ; Lee SY; Hong J
    Eur J Med Chem; 2021 Apr; 215():113272. PubMed ID: 33607457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.